Rumpus Therapeutics is a biopharmaceutical company dedicated to advancing innovative science for neglected pediatric diseases. Our focus is on bringing much needed therapies to those rare and orphan conditions with high morbidity and mortality. Our development efforts span small molecule, protein, and cell & gene therapy platforms. Additional information can be found at https://www.rumpustx.com/.
Company Details
- Founded
- -
- Address
- 300 Brookside Ave, Ambler,pennsylvania 19002,united States
- na****@****stx.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- rumpustx.com
- HQ
- Ambler, Pennsylvania
Rumpus Therapeutics Questions
Rumpus Therapeutics's website is rumpustx.com
Rumpus Therapeutics's LinkedIn profile is https://www.linkedin.com/company/rumpus-therapeutics
Rumpus Therapeutics's industry is
Biotechnology Research
Rumpus Therapeutics's top competitors are
Acadia Pharmaceuticals Inc.,
Nexien Biopharma,
Ceria Therapeutics,
Neos Therapeutics, Inc.,
Aytu Biopharma,
Xeris Pharmaceuticals, Inc.,
Astrazeneca,
Zynex Medical,
Vivus Llc,
Ampio Pharmaceuticals, Inc..
Rumpus Therapeutics's support email address is nate@rumpustx.com
Rumpus Therapeutics's categories are Biotechnology Research
Rumpus Therapeutics's founding year is 2019
